Literature DB >> 29907610

Reply to Agarwal: Activity against nuclear substrates is not necessarily mediated by nuclear Akt.

Thomas A Leonard1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29907610      PMCID: PMC6142218          DOI: 10.1073/pnas.1808882115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  11 in total

1.  Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

Authors:  A Brunet; A Bonni; M J Zigmond; M Z Lin; P Juo; L S Hu; M J Anderson; K C Arden; J Blenis; M E Greenberg
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

2.  Insulin-like growth factor type-I receptor internalization and recycling mediate the sustained phosphorylation of Akt.

Authors:  Robert J Romanelli; Andrew P LeBeau; Clifton G Fulmer; Deborah A Lazzarino; Alan Hochberg; Teresa L Wood
Journal:  J Biol Chem       Date:  2007-06-01       Impact factor: 5.157

3.  PI(3,4,5)P3 Engagement Restricts Akt Activity to Cellular Membranes.

Authors:  Michael Ebner; Iva Lučić; Thomas A Leonard; Ivan Yudushkin
Journal:  Mol Cell       Date:  2017-02-02       Impact factor: 17.970

4.  How to explain the AKT phosphorylation of downstream targets in the wake of recent findings.

Authors:  Anil K Agarwal
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-15       Impact factor: 11.205

5.  Spatio-temporal dynamics of protein kinase B/Akt signaling revealed by a genetically encoded fluorescent reporter.

Authors:  Maya T Kunkel; Qiang Ni; Roger Y Tsien; Jin Zhang; Alexandra C Newton
Journal:  J Biol Chem       Date:  2004-12-06       Impact factor: 5.157

6.  A family with severe insulin resistance and diabetes due to a mutation in AKT2.

Authors:  Stella George; Justin J Rochford; Christian Wolfrum; Sarah L Gray; Sven Schinner; Jenny C Wilson; Maria A Soos; Peter R Murgatroyd; Rachel M Williams; Carlo L Acerini; David B Dunger; David Barford; A Margot Umpleby; Nicholas J Wareham; Huw Alban Davies; Alan J Schafer; Markus Stoffel; Stephen O'Rahilly; Inês Barroso
Journal:  Science       Date:  2004-05-28       Impact factor: 47.728

7.  14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport.

Authors:  Anne Brunet; Fumihiko Kanai; Justine Stehn; Jian Xu; Dilara Sarbassova; John V Frangioni; Sorab N Dalal; James A DeCaprio; Michael E Greenberg; Michael B Yaffe
Journal:  J Cell Biol       Date:  2002-02-25       Impact factor: 10.539

8.  PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling.

Authors:  Laura Braccini; Elisa Ciraolo; Carlo C Campa; Alessia Perino; Dario L Longo; Gianpaolo Tibolla; Marco Pregnolato; Yanyan Cao; Beatrice Tassone; Federico Damilano; Muriel Laffargue; Enzo Calautti; Marco Falasca; Giuseppe D Norata; Jonathan M Backer; Emilio Hirsch
Journal:  Nat Commun       Date:  2015-06-23       Impact factor: 14.919

9.  Localization of mTORC2 activity inside cells.

Authors:  Michael Ebner; Benjamin Sinkovics; Magdalena Szczygieł; Daniela Wolfschoon Ribeiro; Ivan Yudushkin
Journal:  J Cell Biol       Date:  2017-01-31       Impact factor: 10.539

10.  Conformational sampling of membranes by Akt controls its activation and inactivation.

Authors:  Iva Lučić; Manoj K Rathinaswamy; Linda Truebestein; David J Hamelin; John E Burke; Thomas A Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-09       Impact factor: 11.205

View more
  3 in total

Review 1.  PI3K Driver Mutations: A Biophysical Membrane-Centric Perspective.

Authors:  Mingzhen Zhang; Hyunbum Jang; Ruth Nussinov
Journal:  Cancer Res       Date:  2020-10-12       Impact factor: 13.312

Review 2.  Lipid-dependent Akt-ivity: where, when, and how.

Authors:  Katharina M Siess; Thomas A Leonard
Journal:  Biochem Soc Trans       Date:  2019-05-30       Impact factor: 5.407

3.  Structure of autoinhibited Akt1 reveals mechanism of PIP3-mediated activation.

Authors:  Linda Truebestein; Harald Hornegger; Dorothea Anrather; Markus Hartl; Kaelin D Fleming; Jordan T B Stariha; Els Pardon; Jan Steyaert; John E Burke; Thomas A Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-17       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.